A Year in Review: 2025
By
Substantial Research Progress and Fundraising Success
Pilot Recellularization Results
Confirming scaffold viability and cell growth
December Matching Campaign Success!
We crushed our goal! Thank you for raising nearly $60k with the match.
Scaling Up Recellularization, Unprecedented Biomechanics Data, and In Vivo Safety Testing
Larger samples, rigorous testing, and long-term safety data from our labs in Slovakia and Austria.
February 1st, 2026
From pilot success to full-scale protocols—plus, join Jan Kovac and William Musa for an exclusive bioreactor tour.
January 4th, 2026
$62,959 Raised: A Fundraising Win for the New Year!
February 1st, 2025
New Research Begins in Slovakia!
New Research Partnership with Dr. Stanislav Žiaran
Dr. Stanislav Žiaran in Bratislava, Slovakia
January 2nd, 2025
2024 Year-End Research & Development Update
December 1st, 2024
Planning for human trials
Tax Benefits of Crypto Donations to Foregen in 2024
Unlock significant tax advantages!
November 4th, 2024
Gainful progress towards our final goal
October 2nd, 2024
Foregen is preparing for human clinical trials
September 2nd, 2024
A successful meeting between our surgical consultant and the veterinarian team
August 1st, 2024
Developing the human surgical plan, beginning histology study, and exploring new partnerships!
.png)
.png)
Commentarium
by foregen